Position in RPRX
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$8,249,880
+$1,587,649 QoQ
Shares Held
171,980
-0.3% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NOMURA ASSET MANAGEMENT CO LTD holds $214,904,453 across 68 Biotechnology names. RPRX ranks #7 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
121,167 | $54,105,911 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
53,934 | $41,671,564 | |
| 3 | ARGX |
Argenx SE
|
49,306 | $36,005,704 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
93,225 | $30,845,354 | |
| 5 | INSM |
INSMED Inc
|
89,660 | $14,661,203 | |
| 6 | ASND |
Ascendis Pharma A/S
|
43,484 | $9,946,095 | |
| 7 | RPRX |
Royalty Pharma plc
This page
|
171,980 | $8,249,880 | |
| 8 | INCY |
Incyte Corp
|
83,320 | $7,842,077 |
All Filings in RPRX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,249,880 | 171,980 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $6,662,231 | 172,418 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $5,234,493 | 148,370 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $4,094,521 | 113,642 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $3,537,675 | 113,642 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $2,592,887 | 101,642 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $2,875,452 | 101,642 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $2,680,299 | 101,642 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,120,881 | 102,762 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $3,424,142 | 121,899 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $2,526,516 | 93,092 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $2,915,750 | 94,852 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,093,247 | 85,852 | Shares | Sole | 2025-01-10 | |
| 2022-12-31 | $3,155,632 | 79,849 | Shares | Sole | 2025-01-10 | |
| 2022-09-30 | $3,167,751 | 78,839 | Shares | Sole | 2025-01-10 | |
| 2022-06-30 | $3,104,191 | 73,839 | Shares | Sole | 2025-01-10 | |
| 2022-03-31 | $2,681,967 | 68,839 | Shares | Sole | 2025-01-10 | |
| 2021-12-31 | $2,710,158 | 68,009 | Shares | Sole | 2025-01-10 | |
| 2021-09-30 | $1,127,531 | 31,199 | Shares | Sole | 2025-01-10 | |
| 2021-06-30 | $3,168,486 | 77,299 | Shares | Sole | 2025-01-10 | |
| 2021-03-31 | $6,249,001 | 143,260 | Shares | Sole | 2025-01-10 | |
| 2020-12-31 | $6,616,610 | 132,200 | Shares | Sole | 2025-01-10 | |
| 2020-09-30 | $4,274,312 | 101,600 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||